BOS-PFDD – Lung Transplant Foundation
Developing a novel inhaled therapeutic for the treatment of bronchiolitis obliterans syndrome - Research Outreach
Factors affecting complications development and mortality after single lung transplant
General Information
Chronic lung allograft dysfunction following lung transplantation: cha | TRRM
Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
Criteria for diagnosis and staging of BOS | Download Table
Frontiers | Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant
Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation | SpringerLink
Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation | Scientific Reports
Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally | Bone Marrow Transplantation
Novel Biomarkers for Segregating Lung Transplant Rejection Phenotypes. - ATC Abstracts
Chronic lung allograft dysfunction following lung transplantation: cha | TRRM
The Lung Transplant Foundation to Host Externally-Led Patient-Focused Drug Development Meeting to Help Educate FDA on Living with Bronchiolitis Obliterans Syndrome (BOS)
Bronchiolitis obliterans - Wikipedia
Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks | PLOS ONE
BOS - Zambon USA
JCM | Free Full-Text | Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
The respiratory microbiome after lung transplantation: Reflection or driver of respiratory disease? - Eskind - 2021 - American Journal of Transplantation - Wiley Online Library
Imaging Course of Lung Transplantation: From Patient Selection to Postoperative Complications | RadioGraphics
Frontiers | Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers
A novel mechanism for immune regulation after human lung transplantation
Lung Transplant Foundation, FDA Mull Bronchiolitis Obliterans Syndrome
Frontiers | Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry | PLOS ONE
lung transplant research – Lung Transplant Foundation
